Abstract: This study proposes an advanced circuit design to implement a highly digitalized current input third-order sigma-delta modulator (SDM) with enhanced noise transfer function (NTF). The ...
Abstract: This work achieves the desirable combination of low-pressure chemical vapor deposition silicon nitride (SiN) multi-layer photonic integrated circuits (PICs) with high-performance thin-film ...
Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.
The company in 2026 is seeking approval from global regulators for Casgevy and two cystic fibrosis drugs in younger patients.
Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor ...
Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.
Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...
Krystal Biotech (NASDAQ:KRYS) said it has generated positive interim clinical results for its inhaled cystic fibrosis (CF) ...
PITTSBURGH - Krystal Biotech, Inc. (NASDAQ:KRYS) announced Thursday that its experimental gene therapy KB407 successfully delivered and expressed wild-type CFTR protein in the lungs of cystic fibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback